Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients
PROTEOMICS – Clinical Applications · 2023
DOI: 10.1002/prca.202200118 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2023. Verfasst von David Marx und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Kidney Transplantation, Nouvel Hôpital Civil, Strasbourg, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Bone Resorption. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Kidney transplant recipients (KTRs) are at an increased risk of fractures. Total urinary hydroxyproline excretion served as marker for bone resorption (BR) but was replaced by β‐CrossLaps (CTX), a C‐terminal collagen α‐1(I) chain (COL1A1) telopeptide. We investigated the low‐molecular‐weight urinary proteome for peptides associated with changes in bone metabolism after kidney transplantation.
Methods
Clinical and laboratory data including serum levels of CTX in 96 KTR from two nephrology centers were correlated with signal intensities of urinary peptides identified by capillary electrophoresis mass spectrometry.
Results
Eighty‐two urinary peptides were significantly correlated with serum CTX levels. COL1A1 was the predominant peptide source. Oral bisphosphonates were administered for decreased bone density in an independent group of 11 KTR and their effect was evaluated on the aforementioned peptides. Study of the peptides cleavage sites revealed a signature of Cathepsin K and MMP9. Seventeen of these peptides were significantly associated with bisphosphonate treatment, all showing a marked reduction in their excretion levels compared to baseline.
Discussion
This study provides strong evidence for the presence of collagen peptides in the urine of KTR that are associated with BR and that are sensitive to bisphosphonate treatment. Their assessment might become a valuable tool to monitor bone status in KTR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Kidney Transplantation, Nouvel Hôpital Civil, Strasbourg, France.
- INSERM UMR-S1109, FMTS, Strasbourg, France.
- Hospital of Sélestat, Sélestat, France.
- INSERM U1151, Paris, France.
- Department of Nephrology and Kidney Transplantation, Necker Hospital, AP-HP, Paris, France.
- Medical Faculty, Paris University, Paris, France.
Zitieren
APA
Marx, D., Anglicheau, D., Caillard, S., Moulin, B., Kochman, A., Mischak, H., Latosinska, A., Bienaimé, F., Prié, D., Marquet, P., Perrin, P., Gwinner, W., & Metzger, J. (2023). Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202200118
Vancouver
Marx D, Anglicheau D, Caillard S, Moulin B, Kochman A, Mischak H, et al. Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients. PROTEOMICS – Clinical Applications. 2023. doi:10.1002/prca.202200118
BibTeX
@article{Marx2023,
author = {Marx, David and Anglicheau, Dany and Caillard, Sophie and Moulin, Bruno and Kochman, Audrey and Mischak, Harald and Latosinska, Agnieszka and Bienaimé, Frank and Prié, Dominique and Marquet, Pierre and Perrin, Peggy and Gwinner, Wilfried and Metzger, Jochen},
title = {Urinary collagen peptides: Source of markers for bone metabolic processes in kidney transplant recipients},
journal = {PROTEOMICS – Clinical Applications},
year = {2023},
doi = {10.1002/prca.202200118}
}
EUVIMED